Clinical Trial Update: Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 pediatric kidney transplantation trial comparing steroid withdrawal with tacrolimus to a tacrolimus plus mycophenolate mofetil (MMF) induction regimen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Tacrolimus (Prograf) (tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED